Patent · US Active

Macrocyclic inhibitors of hepatitis C virus

US9623022B2 · kind B2 · utility

0Cited by

23References

16Claims

0Family size

Assignees

Janssen Sciences Ireland UC · IE
MEDIVIR AB · SE

Inventors

Kenneth Alan Simmen · Tervuren, BE
Herman Augustinus De Kock · Arendonk, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Lili Hu · Mechelen, BE
Abdellah Tahri · Anderlecht, BE
Dominique Louis Nestor Ghislain Surleraux · Braine-le-Comte, BE
Karl Magnus Nilsson · Vimmerby, SE
Bengt Bertil Samuelsson · Skärholmen, SE
!sa Annica Kristina Rosenquist · Huddinge, SE
Vladimir Ivanov · Moscow, RU
Mikael Pelcman · Ayacucho, PE
Anna Karin Gertrud Linnea Belfrage · Huddinge, SE
Per-Ola Mikael Johansson · Linköping, SE
Sandrine Marie Helene Vendeville · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, BE

Key dates

Filing date	Apr 25, 2016
Grant date	Apr 18, 2017
Priority date	—
Expiry date	Apr 25, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inhibitors of HCV replication of formula (I)and the N-oxides, salts, and stereoisomers, wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.